Mike is Chair of 4 public and private healthcare companies and has 30 years global Health industry experience having previously held senior roles at Align Technology (Amsterdam), Boston Scientific (Paris), C.R. Bard (USA), Sybron (Switzerland) and Becton Dickinson (UK) and was President of Gambro (Sweden) leading the £3bn buyout. Having spent 22 of the last 25 years living and working outside the UK, Mike now works with UK based companies helping address the global market.
Mike Lewis said “Pharmaceutical research is changing to incorporate risk based monitoring. The support from Octopus will help accelerate the TRI offering and allow us to build the team and the tools to help our clients successfully deliver their studies”.
Duncan Hall, CEO and Founder said “We’re delighted to have Mike on board. His breadth and depth of experience in growing businesses in the sector will be invaluable as we grow rapidly in the next few years.”